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Abstract 
Differential diagnosis between pancreatic carcinoma and tumor-forming 
pancreatitis remains difficult, which can cause serious problem because 
the management and prognosis of these two focal pancreatic masses are 
entirely different. We report herein a case of tumor-forming 
pancreatitis mimicking pancreatic carcinoma in an 80-year-old woman. 
Computed tomography revealed a solid mass in the head of the pancreas, 
and endoscopic retrograde cholangiopancreatography showed a complete 
obstruction of the main pancreatic duct in the head of the pancreas. 
Dynamic contrast-enhanced MRI demonstrated a time-signal intensity 
curve (TIC) with a slow rise to a peak (1 min after administration of 
contrast material), followed by a slow decline at the pancreatic mass, 
indicating fibrotic pancreas. Under the diagnosis of tumor-forming 
pancreatitis, the patient underwent a segmental pancreatectomy instead 
of a pancreaticoduodenectomy. The histopathology of the pancreatic mass 
showed chronic pancreatitis without malignancy. The pancreatic TIC 
obtained from dynamic-contrast MRI can be helpful in differentiating 
tumor-forming pancreatitis from pancreatic carcinoma and in avoiding 
any unnecessary major pancreatic surgery. 
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Introduction 
Although various diagnostic modalities have been proposed to 
provide an accurate diagnosis, the differential diagnosis of 
pancreatic carcinoma and tumor-forming pancreatitis remains 
unsettled.1-4 The differential diagnosis between pancreatic 
carcinoma and tumor-forming pancreatitis is exceedingly 
important because there is an extreme difference in the management 
and prognosis of these two pancreatic entities. We have reported 
that a time-signal intensity curve (TIC) of the pancreas obtained 
from dynamic contrast-enhanced magnetic resonance imaging (MRI) 
is a reliable indicator of pancreatic fibrosis.5 In addition, 
pancreatic TIC from dynamic MRI provides dependable information 
for differentiating pancreatic carcinoma from tumor-forming 
pancreatitis.6 We report herein the usefulness of the 
pre-operative pancreatic TIC from dynamic MRI in the diagnosis 
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Case report 
An 80-year-old female was referred to our department for the 
treatment of a mass in the head of the pancreas. She had no 
complaint, and no abnormalities were found on physical examination. 
She had no history of alcohol consumption. Preoperative blood 
examinations were within normal limits, except for elevated 
carbohydrate antigen 19-9 levels of 101 IU/ml (normal range, 0-37 
IU/ml), DU-PAN-2 levels of 560 IU/ml (normal range, 0-150 IU/ml), 
and serum IgG levels of 1850 mg/dl(normal range, 870-1700 
mg/dl)and IgG4 levels of 198 mg/dl (normal range, 4.8-105 mg/dl) . 
Carcinoembryonic antigen levels were within normal limits. 
Computed tomography (CT) revealed a solid mass in the head of the 
pancreas, 3.0 cm in diameter, which showed slight enhancement in 
the delayed phase (Fig. 1). Endoscopic retrograde 
cholangiopancreatography (ERCP) revealed a complete obstruction 
of the main pancreatic duct in the head of the pancreas (Fig. 2). 
There were no malignant cells in pancreatic juice collected by 
endoscopic cannulation and brushing cytology. Dynamic 
contrast-enhanced MRI demonstrated a TIC profile with a slow rise 
to a peak (1 min after administration of contrast material), 
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followed by a slow decline (type-II) at the pancreatic mass in 
the head of the pancreas (Fig. 3). The pancreatic parenchyma distal 
to the mass lesion also showed a type-II TIC. At the nontumorous 
pancreatic parenchyma proximal to the mass lesion, dynamic 
contrast-enhanced MRI showed a TIC profile with a rapid rise to 
a peak (25 s after injection of contrast material), followed by 
a rapid decline (type-I). We thus diagnosed the pancreatic mass 
as being tumor-forming pancreatitis.  The patient underwent 
surgical resection with segmental pancreatectomy instead of 
receiving a pancreaticoduodenectomy. Histopathologic 
examination of the resected pancreatic mass revealed pronounced 
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Discussion 
Preoperative differentiation between tumor-forming pancreatitis 
and pancreatic carcinoma is difficult because the imaging findings 
of these masses are extremely similar.1-4 Recently, various 
diagnostic techniques have been proposed for the accurate 
differential diagnosis of pancreatic masses. Endoscopic 
ultrasound (EUS)-guided fine needle aspiration biopsy has been 
reported to be useful in differential diagnosis of pancreatic mass, 
including tumor-forming pancreatitis and pancreatic carcinoma.7 
Okai et al.8 have reported that EUS combined with ERCP is useful 
for differentiation of tumor-forming pancreatitis from malignant 
tumor, for early diagnosis, and for monitoring therapeutic effects. 
In contrast, Ohtsubo et al.9 have reported that hypermethylation 
analyses of the cancer-specific genes in pure pancreatic juice 
supports differential diagnosis. However, these diagnostic 
modalities are both relatively an invasive. 
 Our previous study on the differentiation of focal 
pancreatic masses with dynamic contrast-enhanced MRI 
demonstrated that TIC profile analysis is useful for the diagnosis 
of pancreatic masses.6 The patterns of pancreatic TIC were 
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classified into 4 types according to the time to a peak: 25 s and 
1, 2, and 3 min after the bolus injection of contrast material, 
namely, type-I, II, III, and IV, respectively. The normal pancreas 
shows the type-I TIC. In the previous study, pancreatic carcinomas 
demonstrated type-III or type-IV TIC, and the type-IV TIC was only 
recognized in pancreatic carcinoma. 6 Meanwhile, tumor-forming 
pancreatitis showed type-II or type-III. The type-III TIC showed 
an overlap in the TIC profile between pancreatic carcinoma and 
tumor-forming pancreatitis. In contrast, the type-II TIC 
exhibited a unique profile indicative of chronic pancreatitis, 
including tumor-forming pancreatitis. In the present case, the 
focal mass lesion demonstrated a type-II TIC. Therefore, we 
diagnosed the mass as tumor-forming pancreatitis, and performed 
segmental pancreatectomy as a total biopsy of the mass lesion.  
 In conclusion, the pancreatic TIC profile from dynamic MRI 
can help to differentiate tumor-forming pancreatitis from 
pancreatic carcinoma. This imaging technique is a less invasive 
diagnostic tool than other diagnostic modalities that enables us 
to eliminate over-diagnosis and/or unnecessary major pancreatic 
surgery.  
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Figure legends 
Fig. 1. Abdominal computed tomography scan showing a solid mass 
3.0 cm in diameter in the pancreatic head. 
 
Fig. 2. Endoscopic retrograde cholangiopancreatography showing 
obstruction of the main pancreatic duct in the pancreatic head. 
 
Fig.3. Dynamic contrast-enhanced MRI showing type-II TIC at the 
pancreatic mass in the pancreatic head. The regions of interest 
are placed at the pancreatic mass (No. 1) and the non-tumorous 
pancreatic parenchyma proximal to the mass lesion (No. 2). 








 T. Kuroki et al. 
 13
 
Fig.3. 
